Media & Resources

NEW YORK, November 29, 2007—In advance of World AIDS Day on December 1, the International AIDS Vaccine Initiative (IAVI) announced that BD, a global medical technology company, will provide the non-profit organization with US$900,000 in cash, equipment and medical supplies over a three–year period. BD’s support, a 50-percent increase on an annual basis over its…

Epidemic requires a vaccine. Perseverance and innovation are key. Volunteers are heroes.

Henry Schein, Inc. Joins BD, Continental Airlines, Google, Merck and Pfizer in the Search for an AIDS Vaccine.

Despite downward revision on HIV/AIDS prevalence data, epidemic requires a vaccine.

Study of Merck vaccine candidate is stopped in South Africa; trial is unblinded.

The International AIDS Vaccine Initiative Applauds the Governments of India, the United Kingdom, and South Africa for their Commitment to Exploring New Financial Incentives to Accelerate AIDS Vaccine R&D.

Though the outcome is disappointing, IAVI urges the field to maintain hope and embrace innovation.

TOKYO & NEW YORK, September 20, 2007—The International AIDS Vaccine Initiative (IAVI), a global organization working to speed the development of preventive AIDS vaccines, will collaborate on the development of a novel AIDS vaccine technology with University of Tokyo faculty member Tetsuro Matano, IAVI announced today. Professor Matano, MD, PhD, will act as a scientific…